Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Elekta B Shs Unsp/Adr (EKTAY)

Elekta B Shs Unsp/Adr (EKTAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Elekta B Shs Unsp/Adr Hagaplan 4 Box 7593 Stockholm V7 SE-113 68 SWE

www.elekta.com Employees: 4,556 P: 46-8-587-254-00

Sector:

Medical

INDUSTRY GROUPING:

Medical Instruments

Description:

Elekta AB is a human care company engaged in developing and selling clinical solutions for the treatment of cancer and neurological diseases. It develops tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. The Company's offering is divided into five areas: Neuroscience, Oncology, Software, Brachytherapy and Services. Elekta AB is headquartered in Stockholm, Sweden.

Key Statistics

Overview:

Market Capitalization, $K 2,265,526
Enterprise Value, $K 2,589,556
Shares Outstanding, K 368,588
Float, K 216,435
% Float 58.72%
Short Interest, K 7
Short Float 0.00%
Days to Cover 1.00
Short Volume Ratio 0.01
% of Insider Shareholders 41.28%
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 1,708 M
Annual Net Income, $ 22,370 K
Last Quarter Sales, $ 430,610 K
Last Quarter Net Income, $ 24,330 K
EBIT, $ 94,730 K
EBITDA, $ 217,880 K

Growth:

1-Year Return -4.25%
3-Year Return -14.21%
5-Year Return -58.02%
5-Year Revenue Growth 12.69%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth -7.69%

Per-Share Information:

Most Recent Earnings 0.07 on 11/26/25
Next Earnings Date 02/20/26 [BMO]
Earnings Per Share ttm 0.29
EPS Growth vs. Prev Qtr 133.33%
EPS Growth vs. Prev Year 16.67%
Annual Dividend & Yield (Paid) 0.12 (2.02%)
Annual Dividend & Yield (Fwd) 0.13 (2.09%)
Most Recent Dividend 0.064 on 09/08/25
Next Ex-Dividends Date 09/08/25
Dividend Payable Date 09/26/25
Dividend Payout Ratio 41.67%

EKTAY Ratios

Ratio
Price/Earnings ttm 21.21
Price/Earnings forward 18.09
Price/Earnings to Growth N/A
Return-on-Equity % 12.14%
Return-on-Assets % 3.79%
Profit Margin % 1.31%
Debt/Equity 0.77
Price/Sales 1.33
Price/Cash Flow 10.05
Price/Book 2.52
Book Value/Share 2.44
Interest Coverage -1.85
60-Month Beta 1.06

EKTAY Dividends

Date Value
09/08/25 $0.0640
03/07/25 $0.0590
09/09/24 $0.0580
02/26/24 $0.0790
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar